Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 16;14(1):85.
doi: 10.3390/brainsci14010085.

The Clinical Relevance of Artificial Intelligence in Migraine

Affiliations
Review

The Clinical Relevance of Artificial Intelligence in Migraine

Angelo Torrente et al. Brain Sci. .

Abstract

Migraine is a burdensome neurological disorder that still lacks clear and easily accessible diagnostic biomarkers. Furthermore, a straightforward pathway is hard to find for migraineurs' management, so the search for response predictors has become urgent. Nowadays, artificial intelligence (AI) has pervaded almost every aspect of our lives, and medicine has not been missed. Its applications are nearly limitless, and the ability to use machine learning approaches has given researchers a chance to give huge amounts of data new insights. When it comes to migraine, AI may play a fundamental role, helping clinicians and patients in many ways. For example, AI-based models can increase diagnostic accuracy, especially for non-headache specialists, and may help in correctly classifying the different groups of patients. Moreover, AI models analysing brain imaging studies reveal promising results in identifying disease biomarkers. Regarding migraine management, AI applications showed value in identifying outcome measures, the best treatment choices, and therapy response prediction. In the present review, the authors introduce the various and most recent clinical applications of AI regarding migraine.

Keywords: artificial intelligence; machine learning; migraine; migraine attack prediction; migraine diagnosis; migraine management; personalised medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Olesen J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1–211. - PubMed
    1. Steiner T.J., Stovner L.J. Global epidemiology of migraine and its implications for public health and health policy. Nat. Rev. Neurol. 2023;19:109–117. doi: 10.1038/s41582-022-00763-1. - DOI - PubMed
    1. Stovner L.J., Nichols E., Steiner T.J., Abd-Allah F., Abdelalim A., Al-Raddadi R.M., Ansha M.G., Barac A., Bensenor I.M., Doan L.P., et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:954–976. doi: 10.1016/S1474-4422(18)30322-3. - DOI - PMC - PubMed
    1. Cevoli S., D’Amico D., Martelletti P., Valguarnera F., Del Bene E., De Simone R., Sarchielli P., Narbone M., Testa L., Genco S., et al. Underdiagnosis and undertreatment of migraine in Italy: A survey of patients attending for the first time 10 headache centres. Cephalalgia. 2009;29:1285–1293. doi: 10.1111/j.1468-2982.2009.01874.x. - DOI - PubMed
    1. Takahashi T.T., Ornello R., Quatrosi G., Torrente A., Albanese M., Vigneri S., Guglielmetti M., De Marco C.M., Dutordoir C., Colangeli E., et al. Medication overuse and drug addiction: A narrative review from addiction perspective. J. Headache Pain. 2021;22:32. doi: 10.1186/s10194-021-01224-8. - DOI - PMC - PubMed

LinkOut - more resources